Peripheral Arterial Disease (PAD) Therapeutics Market Report

Global and Region Peripheral Arterial Disease (PAD) Therapeutics Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：183
  • REPORT CODE：GMM959299
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Peripheral Arterial Disease (PAD) Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Peripheral Arterial Disease (PAD) Therapeuticsmarket, defines the market attractiveness level of Peripheral Arterial Disease (PAD) Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Peripheral Arterial Disease (PAD) Therapeutics industry, describes the types of Peripheral Arterial Disease (PAD) Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Peripheral Arterial Disease (PAD) Therapeutics market and the development prospects and opportunities of Peripheral Arterial Disease (PAD) Therapeutics industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Peripheral Arterial Disease (PAD) Therapeutics market in Chapter 13.

    By Player:

    • Athersys, Inc (US)

    • miRagen Therapeutics, Inc (US)

    • Symic Bio, Inc (US)

    • TheraVasc Inc (US)

    • Multi Gene Vascular Systems Ltd (Israel)

    • Bristol-Myers Squibb Company (US)

    • Merck & Co, Inc (US)

    • Betagenon AB (Sweden)

    • Bayer HealthCare Pharmaceuticals (Germany)

    • AstraZeneca Plc (UK)

    • AnGes MG, Inc (Japan)

    • Sanofi SA (France)

    • ViroMed Co Ltd (Korea)

    • Proteon Therapeutics, Inc (US)

    By Type:

    • Anti-Platelet Drugs

    • Dual Antiplatelet Therapy Drugs

    • Others

    By End-User:

    • Hospitals

    • Clinics

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Peripheral Arterial Disease (PAD) Therapeutics Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Peripheral Arterial Disease (PAD) Therapeutics Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Peripheral Arterial Disease (PAD) Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Peripheral Arterial Disease (PAD) Therapeutics Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Peripheral Arterial Disease (PAD) Therapeutics Market Analysis and Outlook to 2022

    • 7.1 Global Peripheral Arterial Disease (PAD) Therapeutics Consumption (2017-2022)

    • 7.2 United States Peripheral Arterial Disease (PAD) Therapeutics Consumption (2017-2022)

    • 7.3 Europe Peripheral Arterial Disease (PAD) Therapeutics Consumption (2017-2022)

    • 7.4 China Peripheral Arterial Disease (PAD) Therapeutics Consumption (2017-2022)

    • 7.5 Japan Peripheral Arterial Disease (PAD) Therapeutics Consumption (2017-2022)

    • 7.6 India Peripheral Arterial Disease (PAD) Therapeutics Consumption (2017-2022)

    • 7.7 South Korea Peripheral Arterial Disease (PAD) Therapeutics Consumption (2017-2022)

    8 Region and Country-wise Peripheral Arterial Disease (PAD) Therapeutics Market Analysis and Outlook to 2028

    • 8.1 Global Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast (2022-2028)

    • 8.2 United States Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast (2022-2028)

    • 8.3 Europe Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast (2022-2028)

    • 8.4 China Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast (2022-2028)

    • 8.5 Japan Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast (2022-2028)

    • 8.6 India Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast (2022-2028)

    • 8.7 South Korea Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast (2022-2028)

    9 Global Peripheral Arterial Disease (PAD) Therapeutics Market Outlook by Types and Applications to 2022

    • 9.1 Global Peripheral Arterial Disease (PAD) Therapeutics Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Anti-Platelet Drugs Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Dual Antiplatelet Therapy Drugs Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Peripheral Arterial Disease (PAD) Therapeutics Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Peripheral Arterial Disease (PAD) Therapeutics Market Outlook by Types and Applications to 2028

    • 10.1 Global Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Anti-Platelet Drugs Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Dual Antiplatelet Therapy Drugs Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Peripheral Arterial Disease (PAD) Therapeutics Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Peripheral Arterial Disease (PAD) Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Peripheral Arterial Disease (PAD) Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Peripheral Arterial Disease (PAD) Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Peripheral Arterial Disease (PAD) Therapeutics Market Competitive Analysis

    • 14.1 Athersys, Inc (US)

      • 14.1.1 Athersys, Inc (US) Company Details

      • 14.1.2 Athersys, Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Athersys, Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Product and Service

    • 14.2 miRagen Therapeutics, Inc (US)

      • 14.2.1 miRagen Therapeutics, Inc (US) Company Details

      • 14.2.2 miRagen Therapeutics, Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 miRagen Therapeutics, Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Product and Service

    • 14.3 Symic Bio, Inc (US)

      • 14.3.1 Symic Bio, Inc (US) Company Details

      • 14.3.2 Symic Bio, Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Symic Bio, Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Product and Service

    • 14.4 TheraVasc Inc (US)

      • 14.4.1 TheraVasc Inc (US) Company Details

      • 14.4.2 TheraVasc Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 TheraVasc Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Product and Service

    • 14.5 Multi Gene Vascular Systems Ltd (Israel)

      • 14.5.1 Multi Gene Vascular Systems Ltd (Israel) Company Details

      • 14.5.2 Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Product and Service

    • 14.6 Bristol-Myers Squibb Company (US)

      • 14.6.1 Bristol-Myers Squibb Company (US) Company Details

      • 14.6.2 Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Product and Service

    • 14.7 Merck & Co, Inc (US)

      • 14.7.1 Merck & Co, Inc (US) Company Details

      • 14.7.2 Merck & Co, Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Merck & Co, Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Product and Service

    • 14.8 Betagenon AB (Sweden)

      • 14.8.1 Betagenon AB (Sweden) Company Details

      • 14.8.2 Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Product and Service

    • 14.9 Bayer HealthCare Pharmaceuticals (Germany)

      • 14.9.1 Bayer HealthCare Pharmaceuticals (Germany) Company Details

      • 14.9.2 Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Product and Service

    • 14.10 AstraZeneca Plc (UK)

      • 14.10.1 AstraZeneca Plc (UK) Company Details

      • 14.10.2 AstraZeneca Plc (UK) Peripheral Arterial Disease (PAD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 AstraZeneca Plc (UK) Peripheral Arterial Disease (PAD) Therapeutics Product and Service

    • 14.11 AnGes MG, Inc (Japan)

      • 14.11.1 AnGes MG, Inc (Japan) Company Details

      • 14.11.2 AnGes MG, Inc (Japan) Peripheral Arterial Disease (PAD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 AnGes MG, Inc (Japan) Peripheral Arterial Disease (PAD) Therapeutics Product and Service

    • 14.12 Sanofi SA (France)

      • 14.12.1 Sanofi SA (France) Company Details

      • 14.12.2 Sanofi SA (France) Peripheral Arterial Disease (PAD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Sanofi SA (France) Peripheral Arterial Disease (PAD) Therapeutics Product and Service

    • 14.13 ViroMed Co Ltd (Korea)

      • 14.13.1 ViroMed Co Ltd (Korea) Company Details

      • 14.13.2 ViroMed Co Ltd (Korea) Peripheral Arterial Disease (PAD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 ViroMed Co Ltd (Korea) Peripheral Arterial Disease (PAD) Therapeutics Product and Service

    • 14.14 Proteon Therapeutics, Inc (US)

      • 14.14.1 Proteon Therapeutics, Inc (US) Company Details

      • 14.14.2 Proteon Therapeutics, Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Proteon Therapeutics, Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Peripheral Arterial Disease (PAD) Therapeutics

    • Figure Peripheral Arterial Disease (PAD) Therapeutics Picture

    • Table Global Peripheral Arterial Disease (PAD) Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Peripheral Arterial Disease (PAD) Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Peripheral Arterial Disease (PAD) Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Peripheral Arterial Disease (PAD) Therapeutics Consumption by Country (2017-2022)

    • Figure United States Peripheral Arterial Disease (PAD) Therapeutics Consumption and Growth Rate (2017-2022)

    • Table Europe Peripheral Arterial Disease (PAD) Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure China Peripheral Arterial Disease (PAD) Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Japan Peripheral Arterial Disease (PAD) Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure India Peripheral Arterial Disease (PAD) Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure South Korea Peripheral Arterial Disease (PAD) Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Global Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure United States Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Anti-Platelet Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Dual Antiplatelet Therapy Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Anti-Platelet Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Dual Antiplatelet Therapy Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Peripheral Arterial Disease (PAD) Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Peripheral Arterial Disease (PAD) Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    • Table Athersys, Inc (US) (Foundation Year, Company Profile and etc.)

    • Table Athersys, Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Athersys, Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Product and Service

    • Table miRagen Therapeutics, Inc (US) (Foundation Year, Company Profile and etc.)

    • Table miRagen Therapeutics, Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table miRagen Therapeutics, Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Product and Service

    • Table Symic Bio, Inc (US) (Foundation Year, Company Profile and etc.)

    • Table Symic Bio, Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Symic Bio, Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Product and Service

    • Table TheraVasc Inc (US) (Foundation Year, Company Profile and etc.)

    • Table TheraVasc Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table TheraVasc Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Product and Service

    • Table Multi Gene Vascular Systems Ltd (Israel) (Foundation Year, Company Profile and etc.)

    • Table Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Product and Service

    • Table Bristol-Myers Squibb Company (US) (Foundation Year, Company Profile and etc.)

    • Table Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Product and Service

    • Table Merck & Co, Inc (US) (Foundation Year, Company Profile and etc.)

    • Table Merck & Co, Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck & Co, Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Product and Service

    • Table Betagenon AB (Sweden) (Foundation Year, Company Profile and etc.)

    • Table Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Product and Service

    • Table Bayer HealthCare Pharmaceuticals (Germany) (Foundation Year, Company Profile and etc.)

    • Table Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Product and Service

    • Table AstraZeneca Plc (UK) (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca Plc (UK) Peripheral Arterial Disease (PAD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Plc (UK) Peripheral Arterial Disease (PAD) Therapeutics Product and Service

    • Table AnGes MG, Inc (Japan) (Foundation Year, Company Profile and etc.)

    • Table AnGes MG, Inc (Japan) Peripheral Arterial Disease (PAD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table AnGes MG, Inc (Japan) Peripheral Arterial Disease (PAD) Therapeutics Product and Service

    • Table Sanofi SA (France) (Foundation Year, Company Profile and etc.)

    • Table Sanofi SA (France) Peripheral Arterial Disease (PAD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi SA (France) Peripheral Arterial Disease (PAD) Therapeutics Product and Service

    • Table ViroMed Co Ltd (Korea) (Foundation Year, Company Profile and etc.)

    • Table ViroMed Co Ltd (Korea) Peripheral Arterial Disease (PAD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table ViroMed Co Ltd (Korea) Peripheral Arterial Disease (PAD) Therapeutics Product and Service

    • Table Proteon Therapeutics, Inc (US) (Foundation Year, Company Profile and etc.)

    • Table Proteon Therapeutics, Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Proteon Therapeutics, Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US